These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 28274272

  • 21. The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
    Borgquist S, Zhou W, Jirström K, Amini RM, Sollie T, Sørlie T, Blomqvist C, Butt S, Wärnberg F.
    BMC Cancer; 2015 Jun 11; 15():468. PubMed ID: 26062614
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
    Habel LA, Capra AM, Achacoso NS, Janga A, Acton L, Puligandla B, Quesenberry CP.
    Cancer Epidemiol Biomarkers Prev; 2010 Oct 11; 19(10):2488-95. PubMed ID: 20929881
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
    Jørgensen KJ, Gøtzsche PC, Kalager M, Zahl PH.
    Ann Intern Med; 2017 Mar 07; 166(5):313-323. PubMed ID: 28114661
    [Abstract] [Full Text] [Related]

  • 28. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B, Amos A, Fletcher A, Kavanagh AM, Gertig DM.
    Cancer Epidemiol Biomarkers Prev; 2004 Oct 07; 13(10):1569-73. PubMed ID: 15466971
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B, Prichard RS, Al-Hilli Z, Bass GA, Quinn C, O'Doherty A, Rothwell J, Geraghty J, Evoy D, McDermott EW.
    Breast; 2015 Jun 07; 24(3):278-82. PubMed ID: 25771080
    [Abstract] [Full Text] [Related]

  • 31. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
    Innos K, Horn-Ross PL.
    Breast Cancer Res Treat; 2008 Oct 07; 111(3):531-40. PubMed ID: 17978879
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ.
    Sopik V, Sun P, Narod SA.
    Breast Cancer Res Treat; 2018 Feb 07; 167(3):787-795. PubMed ID: 29119353
    [Abstract] [Full Text] [Related]

  • 40. Cancer Outcomes in DCIS Patients Without Locoregional Treatment.
    Ryser MD, Weaver DL, Zhao F, Worni M, Grimm LJ, Gulati R, Etzioni R, Hyslop T, Lee SJ, Hwang ES.
    J Natl Cancer Inst; 2019 Sep 01; 111(9):952-960. PubMed ID: 30759222
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.